Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Net income | $14.8M | $45.7M | $24.7M | $8.93M | $28.1M | $36.6M |
| EPS (diluted) | $1.32 | $3.99 | $2.06 | $0.71 | $2.02 | $2.31 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$62.3M | -$203M | -$130M | -$157M | $198M | -$88.0M |
| Share buybacks | — | — | $10.8M | $2.16M | — | $54.3K |
| Dividends paid | $11.3M | $18.2M | $22.7M | $32.1M | $40.7M | $52.4M |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $29.9M | $47.3M | $65.7M | $8.69M | $148M | $1.68M |
| Total assets | — | $876M | $1.08B | $1.19B | $1.19B | $1.14B |
| Total liabilities | — | $520M | $731M | $821M | $799M | $743M |
| Long-term debt | — | — | $728M | — | $794M | $739M |
| Shareholders' equity | $304M | $356M | $347M | $370M | $393M | $396M |
| Retained earnings | — | $27.7M | $25.1M | -$871K | -$20.3M | -$43.1M |
| Shares (wtd avg diluted) | 11.2M | 11.5M | 12.0M | 12.7M | 13.9M | 15.9M |
Every figure is extracted from SARATOGA INVESTMENT CORP.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.